Korsana Biosciences, Inc. SEC filings
Korsana Biosciences filed 16 documents with the SEC in the last twelve months, the latest report being the 10-Q of 4 August 2026. The latest filing, on 15 October 2026, was a DEF 14A: def 14a.
New to this? How to read this page
- Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
- An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
- The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
- Every filing links to the original on EDGAR, the SEC's own site.
Twelve months of filings
by kindMost of the filings were quarterly and annual reports (6). Results came out 1 time.
Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.
The share price around each results release
close before to close afterOver the last 1 release the share price moved 28.7% on average in the two days around results, the most on 11 Sep 2026 (+28.7%).
Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.
What the company told investors on 8-K
7 filingsKorsana Biosciences's 7 news filings (8-K) were mostly about regulation FD disclosure (4) and material agreement (3).
- Regulation FD disclosureMaterial shared with investors, often slides or a presentation4 · latest 11 Sep 2026
- Material agreementA large contract or deal was signed3 · latest 11 Sep 2026
- Other eventsNews the company chose to file3 · latest 27 Aug 2026
- Change in controlControl of the company changed2 · latest 11 Sep 2026
- Officer or director changeSomeone joined, left or changed role at the top2 · latest 11 Sep 2026
- Acquisition or disposition completedA purchase or sale of a business closed1 · latest 11 Sep 2026
- Results of operationsThe quarterly results release1 · latest 11 Sep 2026
- Unregistered sale of equityShares sold privately1 · latest 11 Sep 2026
- Change to security holders' rightsShareholders' rights changed1 · latest 11 Sep 2026
- Charter or bylaw amendment, or fiscal year changeThe company's rules or fiscal year changed1 · latest 11 Sep 2026
- Code of ethics amendmentThe code of ethics changed1 · latest 11 Sep 2026
- Shell company statusShell company status changed1 · latest 11 Sep 2026
- Shareholder voteResults of a vote at a shareholder meeting1 · latest 27 Aug 2026
Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.
How it compares
every company on the siteThe bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.
Every filing as a table
In the last twelve months Korsana Biosciences, Inc. filed 16 documents with the SEC of the kinds listed here: 7 current reports (8-K), about 4 regulation FD disclosure; 3 material agreement; 3 other events; 2 change in control; 2 officer or director change; 3 quarterly reports (10-Q), 2 amended annual reports (10-K/A), 1 proxy statement (DEF 14A), 1 preliminary proxy (PRE 14A), 1 merger registration (S-4), 1 annual report (10-K). The latest, filed 15 October 2026: DEF 14A, proxy statement. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.
| Filed | Form | What it was about | Period or event date | Filing |
|---|---|---|---|---|
| 15 October 2026 | DEF 14A | proxy statement | 13 November 2026 | EDGAR |
| 5 October 2026 | PRE 14A | preliminary proxy | 5 October 2026 | EDGAR |
| 11 September 2026 | 8-K | Material agreement, Acquisition or disposition completed, Results of operations, Unregistered sale of equity, Change to security holders' rights, Change in control, Officer or director change, Charter or bylaw amendment, or fiscal year change, Code of ethics amendment, Shell company status, Regulation FD disclosure | 8 September 2026 | EDGAR |
| 27 August 2026 | 8-K | Shareholder vote, Other events | 26 August 2026 | EDGAR |
| 25 August 2026 | 8-K | Other events | 25 August 2026 | EDGAR |
| 4 August 2026 | 10-Q | quarterly report | 30 June 2026 | EDGAR |
| 12 May 2026 | 10-Q | quarterly report | 31 March 2026 | EDGAR |
| 30 April 2026 | 10-K/A | amended annual report | 31 December 2025 | EDGAR |
| 20 April 2026 | S-4 | merger registration | EDGAR | |
| 1 April 2026 | 8-K | Material agreement, Change in control, Officer or director change, Regulation FD disclosure | 1 April 2026 | EDGAR |
| 30 March 2026 | 10-K | annual report | 31 December 2025 | EDGAR |
| 17 February 2026 | 8-K | Regulation FD disclosure | 17 February 2026 | EDGAR |
| 6 January 2026 | 8-K | Material agreement, Regulation FD disclosure | 3 January 2026 | EDGAR |
| 1 December 2025 | 8-K | Other events | 1 December 2025 | EDGAR |
| 12 November 2025 | 10-Q | quarterly report | 30 September 2025 | EDGAR |
| 12 November 2025 | 10-K/A | amended annual report | 31 December 2024 | EDGAR |